{"id":"W2100751052","doi":"10.1158/0008-5472.can-08-2819","title":"Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":862,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada; American Cancer Society","keywords":"Pancreatic cancer; Epithelial–mesenchymal transition; Gemcitabine; Cancer research; Cisplatin; Biology; Gene silencing; Drug resistance; Gene expression profiling; Cancer; Gene expression; Internal medicine; Gene; Medicine; Metastasis; Chemotherapy; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}